Pim2 complements Flt3 wild-type receptor in hematopoietic progenitor cell transformation

被引:0
|
作者
S Agrawal
S Koschmieder
N Bäumer
N G P Reddy
W E Berdel
C Müller-Tidow
H Serve
机构
[1] Hematology and Oncology,Department of Medicine
[2] University of Münster,undefined
[3] Medizinische Klinik II,undefined
[4] Johann Wolfgang Goethe Universität,undefined
来源
Leukemia | 2008年 / 22卷
关键词
acute myeloid leukemia; signal transduction; cell cycle regulation; pim kinases; Fms-like tyrosine kinase-3;
D O I
暂无
中图分类号
学科分类号
摘要
Pim2 is a serine/threonine kinase expressed at high levels in several malignancies including acute leukemia. Pim2 protein is induced by oncogenic Fms-like tyrosine kinase-3 (Flt3)-internal tandem duplications (ITD), but not by Flt3 wild-type receptor (Flt3-Wt) in response to Flt3 ligand (FL). Here we show that Pim2 can complement Flt3-Wt signaling and induce transformation similar to Flt3-ITD in myeloid cells. Our data demonstrate that Pim2 is necessary but not sufficient for Flt3-ITD-induced transformation of 32D cells and primary bone marrow cells as assessed by colony assays. Pim2-induced clonogenic growth of FL-treated 32D-Flt3-Wt cells. Proliferation of 32D-Flt3-Wt cells was significantly enhanced in FL-treated Pim2-overexpressing cells. This increase was associated with enhanced S-phase cell cycle progression. Pim2-overexpressing cells were resistant to apoptosis induced by growth factor deprivation or treatment with tyrosine kinase inhibitor (PKC412). The Flt3 point mutant D835Y, which is not able to support colony growth of myeloid cells, also induced clonogenic growth in the presence of Pim2. In conclusion, Pim2 is an important target of Flt3-ITD-induced transformation, and overexpression of Pim2 together with Flt3-Wt or D835Y receptor mimics Flt3-ITD-mediated transformation. Pim2 complements with Flt3-Wt signaling to induce proliferation by enhancing G1/S-phase progression of the cell cycle.
引用
收藏
页码:78 / 86
页数:8
相关论文
共 50 条
  • [41] Human Cytomegalovirus Encodes a Novel FLT3 Receptor Ligand Necessary for Hematopoietic Cell Differentiation and Viral Reactivation
    Crawford, Lindsey B.
    Kim, Jung Heon
    Collins-McMillen, Donna
    Lee, Byeong-Jae
    Landais, Igor
    Held, Christine
    Nelson, Jay A.
    Yurochko, Andrew D.
    Caposio, Patrizia
    MBIO, 2018, 9 (02):
  • [42] Prognostic Impact of Mutant to Wild-Type Ratio and Insertion Site in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication
    Kayser, Sabine
    Schlenk, Richard F.
    Krauter, Juergen
    Koehne, Claus-Henning
    Germing, Ulrich
    Held, Gerhard
    Horst, Heinz A.
    Ringhoffer, Mark
    von Lilienfeld-Toal, Marie
    Rummel, Mathias J.
    Goetze, Katharina
    Nachbaur, David
    Schlegelberger, Brigitte
    Goehring, Gudrun
    Salih, Helmut R.
    Martin, Hans
    Herr, Wolfgang
    Luebbert, Michael
    Salwender, Hans-Juergen
    Erdmann, Patricia
    Paschka, Peter
    Gaidzik, Verena I.
    Teleanu, Veronica
    Spaeth, Daniela
    Ganser, Arnold
    Fischer, Thomas
    Doehner, Hartmut
    Doehner, Konstanze
    BLOOD, 2012, 120 (21)
  • [43] Survivin mediates aberrant hematopoietic progenitor cell proliferation and acute leukemia in mice induced by internal tandem duplication of Flt3
    Fukuda, Seiji
    Singh, Pratibha
    Moh, Akira
    Abe, Mariko
    Conway, Edward M.
    Boswell, H. Scott
    Yamaguchi, Seiji
    Fu, Xin-Yuan
    Pelus, Louis M.
    BLOOD, 2009, 114 (02) : 394 - 403
  • [44] Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: Possible application for cancer immunotherapy
    Harada, Sachio
    Kimura, Takafumi
    Fujiki, Hiroshi
    Nakagawa, Hitoshi
    Ueda, Yuji
    Itoh, Tsuyoshi
    Yamagishi, Hisakazu
    Sonoda, Yoshiaki
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 30 (06) : 1461 - 1468
  • [45] An Interferon-γ/FLT3 Axis Positively Regulates Hematopoietic Progenitor Cell Expansion from Human Pluripotent Stem Cells
    Kitajima, Kenji
    Shingai, Minako
    Ando, Hikaru
    Hamasaki, Mako
    Hara, Takahiko
    STEM CELLS, 2022, 40 (10) : 906 - 918
  • [46] Immunization with wild-type p53 gene sequences coadministered with Flt3 ligand induces an antigen-specific type 1 T-cell response
    Parajuli, P
    Pisarev, V
    Sublet, J
    Steffel, A
    Varney, M
    Singh, R
    LaFace, D
    Talmadge, JE
    CANCER RESEARCH, 2001, 61 (22) : 8227 - 8234
  • [47] Efficacy of RNAi-induced down-regulation of wild-type FLT3 on NF-κB pathway in THP-1 cell line
    Lu, Jie
    Yue, Baohong
    Wang, Chunmei
    Bai, Songting
    Sheng, Guangyao
    LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION, 2008, 5 (02): : 15 - 20
  • [48] FLT3 ITD and NUP98 translocations Cooperate to Induce Type I Interferon Signaling That Impedes Hematopoietic Progenitor Differentiation
    Li, Yanan
    Yang, Wei
    Rodriguez-Lopez, Priscilla
    Patel, Riddhi M.
    Casey, Emily B.
    Denby, Elisabeth
    Magee, Jeffrey A.
    BLOOD, 2021, 138
  • [49] Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1
    Janssen, Maike
    Schmidt, Christina
    Bruch, Peter-Martin
    Blank, Maximilian F.
    Rohde, Christian
    Waclawiczek, Alexander
    Heid, Daniel
    Renders, Simon
    Goellner, Stefanie
    Vierbaum, Lisa
    Besenbeck, Birgit
    Herbst, Sophie A.
    Knoll, Mareike
    Kolb, Carolin
    Przybylla, Adriana
    Weidenauer, Katharina
    Ludwig, Anne Kathrin
    Fabre, Margarete
    Gu, Muxin
    Schlenk, Richard F.
    Stoelzel, Friedrich
    Bornhaeuser, Martin
    Roellig, Christoph
    Platzbecker, Uwe
    Baldus, Claudia
    Serve, Hubert
    Sauer, Tim
    Raffel, Simon
    Pabst, Caroline
    Vassiliou, George
    Vick, Binje
    Jeremias, Irmela
    Trumpp, Andreas
    Krijgsveld, Jeroen
    Mueller-Tidow, Carsten
    Dietrich, Sascha
    BLOOD, 2022, 140 (24) : 2594 - 2610
  • [50] SU5416 and SU5614 inhibit wild-type and activated mutant FLT3 signaling in leukemia cells.
    Yee, KWH
    O'Farrell, AM
    Smolich, BD
    Cherrington, JM
    Wait, CL
    Griffith, DJ
    McGreevey, LS
    Heinrich, MC
    BLOOD, 2001, 98 (11) : 838A - 838A